Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rebecca R Vanderpool

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
CHEST Pulmonary|November 11, 2024
Association of Male Sex With Worse Right Ventricular Function and Survival in Pulmonary Hypertension in the Redefining Pulmonary Hypertension Through Pulmonary Vascular Disease Phenomics CohortNicholas J Shelburne, Hui Nian, Gerald J Beck, et al.
Cardiovascular Research|October 16, 2016
TSP1-CD47 signaling is upregulated in clinical pulmonary hypertension and contributes to pulmonary arterial vasculopathy and dysfunctionNatasha M Rogers, Maryam Sharifi-Sanjani, Mingyi Yao, et al.
Circulation. Heart Failure|September 4, 2023
Classification and Predictors of Right Ventricular Functional Recovery in Pulmonary Arterial HypertensionFranz P Rischard, Roberto J Bernardo, Rebecca R Vanderpool, et al.
Medrxiv : the Preprint Server for Health Sciences|February 24, 2023
Classification and Predictors of Right Ventricular Functional Recovery in Pulmonary Arterial HypertensionFranz P Rischard, Roberto J Bernardo, Rebecca R Vanderpool, et al.
Pulmonary Circulation|January 3, 2025
Precision Medicine for Pulmonary Vascular Disease: The Future Is Now (2023 Grover Conference Series)Lindsay M Forbes, Natalie Bauer, Aritra Bhadra, et al.
Pulmonary Circulation|December 25, 2023
Real-world evidence to advance knowledge in pulmonary hypertension: Status, challenges, and opportunities. A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative's Real-world Evidence Working GroupKellie Morland, Christian Gerges, Jean Elwing, et al.
The Journal of Clinical Investigation|August 23, 2016
Vascular stiffness mechanoactivates YAP/TAZ-dependent glutaminolysis to drive pulmonary hypertensionThomas Bertero, William M Oldham, Katherine A Cottrill, et al.
Aging Cell|February 3, 2023
Loss of DNA repair mechanisms in cardiac myocytes induce dilated cardiomyopathyChathurika Henpita, Rajesh Vyas, Chastity L Healy, et al.
Journal of the American College of Cardiology|April 23, 2021
NHLBI-CMREF Workshop Report on Pulmonary Vascular Disease Classification: JACC State-of-the-Art ReviewWilliam M Oldham, Anna R Hemnes, Micheala A Aldred, et al.
Journal of the American College of Cardiology|August 11, 2022
Clinical Characteristics and Transplant-Free Survival Across the Spectrum of Pulmonary Vascular DiseaseAnna R Hemnes, Jane A Leopold, Milena K Radeva, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
CHEST Pulmonary|November 11, 2024
Association of Male Sex With Worse Right Ventricular Function and Survival in Pulmonary Hypertension in the Redefining Pulmonary Hypertension Through Pulmonary Vascular Disease Phenomics CohortNicholas J Shelburne, Hui Nian, Gerald J Beck, et al.
Cardiovascular Research|October 16, 2016
TSP1-CD47 signaling is upregulated in clinical pulmonary hypertension and contributes to pulmonary arterial vasculopathy and dysfunctionNatasha M Rogers, Maryam Sharifi-Sanjani, Mingyi Yao, et al.
Circulation. Heart Failure|September 4, 2023
Classification and Predictors of Right Ventricular Functional Recovery in Pulmonary Arterial HypertensionFranz P Rischard, Roberto J Bernardo, Rebecca R Vanderpool, et al.
Medrxiv : the Preprint Server for Health Sciences|February 24, 2023
Classification and Predictors of Right Ventricular Functional Recovery in Pulmonary Arterial HypertensionFranz P Rischard, Roberto J Bernardo, Rebecca R Vanderpool, et al.
Pulmonary Circulation|January 3, 2025
Precision Medicine for Pulmonary Vascular Disease: The Future Is Now (2023 Grover Conference Series)Lindsay M Forbes, Natalie Bauer, Aritra Bhadra, et al.
Pulmonary Circulation|December 25, 2023
Real-world evidence to advance knowledge in pulmonary hypertension: Status, challenges, and opportunities. A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative's Real-world Evidence Working GroupKellie Morland, Christian Gerges, Jean Elwing, et al.
The Journal of Clinical Investigation|August 23, 2016
Vascular stiffness mechanoactivates YAP/TAZ-dependent glutaminolysis to drive pulmonary hypertensionThomas Bertero, William M Oldham, Katherine A Cottrill, et al.
Aging Cell|February 3, 2023
Loss of DNA repair mechanisms in cardiac myocytes induce dilated cardiomyopathyChathurika Henpita, Rajesh Vyas, Chastity L Healy, et al.
Journal of the American College of Cardiology|April 23, 2021
NHLBI-CMREF Workshop Report on Pulmonary Vascular Disease Classification: JACC State-of-the-Art ReviewWilliam M Oldham, Anna R Hemnes, Micheala A Aldred, et al.
Journal of the American College of Cardiology|August 11, 2022
Clinical Characteristics and Transplant-Free Survival Across the Spectrum of Pulmonary Vascular DiseaseAnna R Hemnes, Jane A Leopold, Milena K Radeva, et al.
Pageof 5